00673.HK
China Health Group Limited
HKSE · Healthcare · Medical - Distribution · HK
HKD 0.32
+0.00%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 80.0M | 41.1M | 38.9M | 59.9M | 76.4M |
| Cost of Revenue | 63.7M | 34.0M | 29.7M | 46.3M | 49.2M |
| Gross Profit | 16.4M | 7.1M | 9.2M | 13.6M | 27.2M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 121.4M | 52.6M | 68.8M | 51.1M | 40.0M |
| General & Admin Expense | 73.6M | — | 62.7M | 33.3M | 28.3M |
| Selling & Marketing Expense | 8.0M | — | 6.1M | 17.8M | 11.7M |
| Other Expenses | 7.5M | — | 7.5M | — | 141.0K |
| Total Operating Expenses | 128.9M | 52.6M | 76.4M | 49.8M | 43.5M |
| Cost and Expenses | 192.6M | 86.5M | 106.1M | 96.0M | 92.7M |
| Operating Income (EBIT) | (112.6M) | (45.4M) | (67.1M) | (37.7M) | (16.3M) |
| Non-Operating | |||||
| Interest Income | 10.0K | 1.0K | 9.0K | 920.0K | 439.0K |
| Interest Expense | 924.0K | 187.0K | 252.0K | 327.0K | 2.2M |
| Net Interest Income | (914.0K) | (186.0K) | (243.0K) | 593.0K | (1.8M) |
| Other Non-Op Income/Expense | (3.7M) | (3.4M) | (252.0K) | (4.6M) | (23.1M) |
| Non-Operating Income (excl Interest) | 16.7M | — | 7.7M | 4.3M | 20.9M |
| EBT (Pre-Tax Income) | (116.2M) | (48.9M) | (67.4M) | (42.3M) | (35.4M) |
| Income Tax Expense | 116.0K | (427.0K) | 443.0K | 203.0K | 177.0K |
| Bottom Line | |||||
| Net Income | (116.2M) | (47.9M) | (67.8M) | (40.2M) | (42.0M) |
| Earnings from Cont. Ops | (116.2M) | (48.4M) | (67.8M) | (42.5M) | (35.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (116.2M) | (47.9M) | (67.8M) | (40.2M) | (42.0M) |
| Per Share | |||||
| Basic EPS | (HK$0.17) | (HK$0.05) | (HK$0.14) | (HK$0.08) | (HK$0.10) |
| Diluted EPS | (HK$0.17) | (HK$0.05) | (HK$0.14) | (HK$0.08) | (HK$0.10) |
| Revenue Per Share | HK$0.06 | HK$0.04 | HK$0.08 | HK$0.13 | HK$0.18 |
| Shares | |||||
| Basic Shares Outstanding | 1.4B | 967.0M | 484.2M | 475.5M | 426.4M |
| Diluted Shares Outstanding | 1.4B | 967.0M | 484.2M | 475.5M | 426.6M |
| Profitability Metrics | |||||
| EBITDA | (107.2M) | (43.3M) | (63.7M) | (37.4M) | (33.0M) |
| D&A | 5.4M | 2.1M | 3.4M | 4.5M | 4.2M |
| EBIT | (112.6M) | (45.4M) | (67.1M) | (42.0M) | (37.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026